Free Access
Med Sci (Paris)
Volume 29, Number 4, Avril 2013
Page(s) 339 - 340
Section Éditorial
Published online 26 April 2013
  1. Barré-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983 ; 220 : 868–871. [CrossRef] [PubMed] [Google Scholar]
  2. Supervie V. Les moyens de prévention de l’infection à VIH à base d’antirétroviraux : quel impact sur l’épidémie du VIH ? Med Sci (Paris) 2013 ; 29 : 373–382. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010 ; 363 : 2587–2599. [CrossRef] [PubMed] [Google Scholar]
  4. Champenois K, Le Gall JM, Jacquemin C, et al. ANRS-COM’TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men. BMJ Open 2012 ; 2 : e000693. [CrossRef] [PubMed] [Google Scholar]
  5. Barnighausen T, Tanser F, Dabis F, Newell ML. Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence. Curr Opin HIV AIDS 2012 ; 7 : 140–150. [CrossRef] [PubMed] [Google Scholar]
  6. Blanc FX, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011 ; 365 : 1471–1481. [CrossRef] [PubMed] [Google Scholar]
  7. Deeks SG, Autran B, Berkhout B, et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 2012 ; 12 : 607–614. [CrossRef] [PubMed] [Google Scholar]
  8. Sáez-Cirión A, Bacchus C, Hocqueloux L, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the Interruption of early initiated antiretroviral therapy ANRS Visconti study. PLoS Pathog 2013 ; 9 : e1003211. [CrossRef] [PubMed] [Google Scholar]
  9. Goujard C, Girault I, Rouzioux C, et al. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy. Antiviral Ther 2012 ; 17 : 1001–1009. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.